90
Participants
Start Date
October 31, 2016
Primary Completion Date
July 31, 2022
Study Completion Date
June 30, 2026
Stereotactic Ablative Radiotherapy (SABR)
Patients will receive stereotactic ablative radiotherapy to all sites of progressive disease, with continuation of current systemic agents.
Standard of Care Treatment
"May include:~* Continue with current systemic agent(s)~* Observation~* Switch to next-line treatment~Palliative radiotherapy is allowed in this arm."
Alberta Health Services-Cross Cancer Institute, Edmonton
BC Cancer - Prince George, Prince George
BC Cancer Fraser Valley Centre, Surrey
BC Cancer Agency Branch, Vancouver
BC Cancer - Victoria Centre, Victoria
London Regional Cancer Program, London
Princess Margaret Cancer Centre, Toronto
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER